Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral ...
You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. LEWISTON — Looking back, Rosie Boyce does not recall experiencing many ...
European regulators have recommended expanding Maviret, a dual direct-acting antiviral, to include acute hepatitis C infection in adults and children.
AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of MAVIRET® ...
AbbVie said the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion recommending the approval of its treatment for acute hepatitis C. The final ...
Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more ...
WASHINGTON -- Liver cancer risk after hepatitis C virus (HCV) cure was significantly greater in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a ...
Millions of Americans live with chronic hepatitis and may not know it, because it can take years to become symptomatic. The most common types of the virus, hepatitis B and C, can lead to liver failure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results